In vivo effects of pharmacological inhibition of A<sub>3</sub>AR.
- Catalina Kretschmar (848445)
- Carlos Oyarzún (848446)
- Cristopher Villablanca (848447)
- Catherinne Jaramillo (848448)
- Sebastián Alarcón (848449)
- Gustavo Perez (848450)
- Montserrat M. Díaz-Encarnación (848451)
- Marçal Pastor-Anglada (189362)
- Wallys Garrido (848452)
- Claudia Quezada (848453)
- Rody San Martín (848454)
Publication date
January 2016
DOIAbstract
<p>Diabetic rats were treated with the adenosine A<sub>3</sub> receptor antagonist MRS1220 from days 31 to 60 post diabetes induction, A. Representative inmunohistochemical detection of α-SMA in cortical areas of kidney sections from untreated (control), diabetic (vehicle-treated rats) and MRS1220-treated diabetic rats. Original magnifications 400X. B. The graph shows quantitative results derived from staining analyses of consecutive field from three animals per group using the UN-SCANIT 2.0 software. Values of control samples were normalized to 1. * <i>P</i> < 0.05 vs control.</p
Add to ORKG